Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis

International Journal of Cancer

Volumn 79, Issue 1, 1998, Pages 19-22

  Koomägi, Reet ^a   Volm, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; THROMBOPLASTIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER RESISTANCE; CANCER SURGERY; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; THROMBOPLASTIN;

EID: 2642668464     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980220)79:1<19::AID-IJC4>3.0.CO;2-Z     Document Type: Article

References (25)

1. BACH, R., Tissue factor. Crit. Rev. Biochem., 23, 339-368 (1988).
2. CALLANDER, N.S., VARKI, N. and RAO, V.M., Immunohistochemical identification of tissue factor in solid tumors. Cancer, 5, 1194-1201 (1992).
3. CARMELIET, P. and 13 OTHERS, Role of tissue factor in embryonic blood-vessel development. Nature (Lond.), 9, 73-75 (1996).
4. CARR, D.T. and MOUNTAIN, C.F., Staging lung cancer. In: M.J. Strauss (ed.), Lung cancer. Clinical diagnosis and treatment, pp. 151-161. Grune and Stratton, New York (1977).
5. CONTRINO, J., HAIR, G., KREUTZER, D. and RICKLES, F.R., In situ detection of tissue factor, in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Med., 2, 209-214 (1996).
6. FISCHER, E.G., RUF, W. and MUELLER, B.M., Tissue-factor initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res., 5, 1629-1632 (1995).
7. FLÖSSEL, C., LUTHER, T., MÜLLER, M., ALBRECHT, S. and KASPER, M., Immunohistochemical detection of tissue factor on paraffin sections of routinely fixed human tissue. Histochemistry, 101, 449-453 (1994).
8. HONN, K.V., TANG, D.G. and CRISSMAN, J.D., Platelets and cancer metastasis: a causal relationship? Cancer Metast. Rev., 11, 325-351 (1992).
9. KAKKAR, A.K., ELLIS, I.O., BLAMEY, R.W. and WILLIAMSON, R.C., Tissue factor: a new independent prognostic marker in breast cancer. Proc. Ann. Meet. Amer. Ass. Cancer Res., 37, A1373 (1996).
10. KAPLAN, E.L. and MEIER, P., Non-parametric estimation from incomplete observations. J. Amer. Statist. Ass., 53, 457-481 (1956).
11. KOOMÄGI, R., MATTERN, J. and VOLM, M., Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis, 9, 2129-2133 (1995).
12. KWAAN, H.C., The plasminogen-plasmin system in malignancy. Cancer Metast. Rev., 11, 291-311 (1994).
13. MAEDA, K., CHUNG, Y.S., OGAWA, Y., TAKATSUKA, S., KANG, S.M., OGAWA, M., SAWADA, T. and SOWA, M., Prognostic value of vascular-endothelial-growth-factor expression in gastric carcinoma. Cancer, 77, 858-863 (1996).
14. MASANEK, U., STAMMLER, G. and VOLM, M., Messenger RNA expression of resistance proteins and related factors in human ovarian-carcinoma cell lines resistant to doxorubicin, taxol and cisplatin. Anti-Cancer Drugs, 8, 189-198 (1997).
15. NEMERSON, Y., Tissue factor and hemostasis. Blood, 71, 1-8 (1988).
16. SHOJI, M., CASPER, K., MICKO, C. and RICKLES, F., Co-expression of tissue factor and VEGF in human melanoma. Proc. Ann. Meet. Amer. Ass. Cancer Res., 37, A426 (1996).
17. TOI, M., HOSHINA, S., TAKAYANAGI, T. and TOMINAGA, T., Association of vascular-endothelial-growth-factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jap. J. Cancer Res., 85, 1045-1049 (1994).
18. VOLM, M., KOOMÄGI, R. and MATTERN, J., Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small-cell lung carcinoma. Anticancer Res., 16, 213-218 (1996).
19. VOLM, M., KOOMÄGI, R. and MATTERN, J., Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous-cell lung cancer. Int. J. Cancer (Pred. Oncol.), 74, 64-68 (1997).
20. VOLM, M., MATTERN, J. and SAMSEL, B., Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein, and glutathione S-transferase π in human lung tumors. Cancer, 71, 3181-3187 (1993).
21. VOLM, M., WAYSS, K., KAUFMANN, M. and MATTERN, J., Pre-therapeutic detection of tumour resistance and the results of tumour chemotherapy. Europ. J. Cancer, 15, 983-993 (1979).
22. WOJTUKIEVICZ, M.Z., ZACHARSKI, L.R., MEMOLI, V.A., KISIEL, W., KUDRYK, B.J., ROUSSEAU, S.M., Abnormal regulation of coagulation/fibrinolysis in small-cell carcinoma of the lung. Cancer, 65, 481-486 (1990).
23. WORLD HEALTH ORGANIZATION: Histological typing of lung tumours. Tumori, 6, 253-272 (1981).
24. ZACHARSKI, L., SCHNED, A.R. and SORENSON, G.D., Occurrence of fibrin and tissue-factor antigen in human small-cell carcinoma of the lung. Cancer Res., 43, 3963-3968 (1983).
25. ZHANG, Y., DENG, Y., LUTHER, T., MÜLLER, M., ZIEGLER, R., WALDHERR, R., STERN, D.M. and NAWROTH, P., Tissue factor controls the balance of angiogenic and anti-angiogenic properties of tumor cells in mice. J. Clin. Invest., 9, 1320-1327 (1994).